Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 63 Carcinoma, Hepatocellular 55 Lung Neoplasms 32 Breast Neoplasms 29 Small Cell Lung Carcinoma 23 Neoplasms 21 Triple Negative Breast Neoplasms 18 Neoplasm Metastasis 17 Urinary Bladder Neoplasms 15 Carcinoma, Transitional Cell 15 Melanoma 14 Colorectal Neoplasms 14 Glioblastoma 10 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Head and Neck Neoplasms 9 Recurrence 8 Liver Neoplasms 8 Endometrial Neoplasms 8 Carcinoma, Renal Cell 8 Mesothelioma, Malignant 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Rectal Neoplasms 5 Kidney Neoplasms 5 Gastrointestinal Neoplasms 5 Carcinoma, Squamous Cell 5 Pancreatic Neoplasms 4

Interventions

Gemcitabine 58 Cisplatin 41 Capecitabine 27 Oxaliplatin 25 durvalumab 16 Fluorouracil 16 Leucovorin 15 S 1 (combination) 11 lenvatinib 10 Nivolumab 10 Irinotecan 10 pembrolizumab 8 apatinib 8 Immune Checkpoint Inhibitors 7 130-nm albumin-bound paclitaxel 7 tremelimumab 6 Bevacizumab 6 camrelizumab 5 Trastuzumab 5 Drug Therapy 5 Blood Specimen Collection 5 Albumin-Bound Paclitaxel 5 tislelizumab 4 irinotecan sucrosofate 4 Taxes 4 Liquid Biopsy 4 Folfox protocol 4 toripalimab 3 surufatinib 3 gemcitabine-oxaliplatin regimen 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Biliary Tract Neoplasms × atezolizumab × Clear all

NCT05052099 2025-09-29

COMBATBIL

University Hospital, Essen

Phase 1/2 Completed

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡